Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04282044
Title Study of CRX100 in Patients With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors BioEclipse Therapeutics
Indications

osteosarcoma

triple-receptor negative breast cancer

hepatocellular carcinoma

rectum adenocarcinoma

ovary epithelial cancer

colon adenocarcinoma

stomach cancer

Therapies

CRX100

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.